Ixico extends commitment to Dementias Platform UK
26th Jan 2022 16:02
(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.
Read moreIxico tapped for another phase-3 clinical trial
1st Nov 2021 15:43
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.
Read moreIxico FY revenues projected to beat expectations
18th Oct 2021 09:33
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were projected to have beat expectations despite falling shy of prior year comparatives.
Read moreIxico secures new contract valued at more than $750,000
22nd Sep 2021 11:19
(Sharecast News) - AI data analytics firm Ixico has secured a new contract valued at more than $750,000 over two years for advanced neuroimaging solutions.
Read moreIxico awarded phase 1 clinical trial contract
8th Sep 2021 12:47
(Sharecast News) - Neuroscience artificial intelligence (AI) company Ixico has been awarded a contract by a new biopharmaceutical client to support its phase 1 multiple system atrophy clinical trial, it announced on Wednesday.
Read moreIxico confident as full-year revenue, earnings decline
6th Aug 2021 14:53
(Sharecast News) - Data analytics company Ixico updated the market on its trading on Friday, confirming that despite a "challenging" business environment, it expected to deliver £8.7m in revenues for the 2021 financial year.
Read moreIxico H1 revenues grow despite Covid-19 impacts on clinical development sector
26th Apr 2021 09:06
(Sharecast News) - Clinical research firm Ixico said on Monday that revenues were expected to have improved in the six months ended 31 March, despite the impacts of the Covid-19 pandemic on the clinical development sector.
Read moreIxico strikes collaboration deal with Microsoft
15th Mar 2021 10:13
(Sharecast News) - Data analytics company Ixico said on Monday that it had struck a collaboration agreement with tech giant Microsoft to develop its artificial intelligence analytics platform for the global pharmaceutical industry.
Read moreIxico selected for Alzheimer's clinical trial
10th Mar 2021 14:30
(Sharecast News) - Neuroscience artificial intelligence (AI) analytics company Ixico has been selected by a current mid-sized biopharmaceutical client to support a phase 2 Alzheimer's disease clinical trial, it announced on Wednesday.
Read moreIxico awarded ?3.4m contract by existing client
24th Dec 2020 12:20
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been awarded a £3.4m contract to run over 4.5 years by an existing client, it announced on Thursday, for a spinocerebellar ataxia type-3 (SCA3) trial.
Read moreIxico to provide neuroimaging solutions to unnamed global pharmaceutical group
8th Dec 2020 09:26
(Sharecast News) - Data analytics firm Ixico has secured a contract for neuroimaging solutions with a "large global pharmaceutical company".
Read moreIxico executes contract for Huntington's disease clinical trial
27th Nov 2020 12:09
(Sharecast News) - Neuroscience data analytics company Ixico has executed a contract to provide neuroimaging services that would support a phase 1b and 2 clinical trial for Huntington's disease, it announced on Friday.
Read moreIxico wins new contracts in Alzheimer's clinical trials
3rd Nov 2020 10:43
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Alzheimer's disease (AD) clinical trials, it announced on Tuesday.
Read moreIxico secures two Huntington's disease clinical trial contracts
22nd Oct 2020 15:00
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Huntington's disease clinical trials.
Read moreIxico FY revenues grow by more than a quarter
19th Oct 2020 09:38
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.
Read more